Yu Zhe, Sun Honghui, Fan Qingyu, Long Hua, Yang Tongtao, Ma Bao'an
Center of Orthopedic Surgery, Orthopedics Oncology Institute of Chinese PLA, Tangdu Hospital, Fourth Military Medical University, Shaanxi 710038, PR China.
Oncol Rep. 2009 May;21(5):1175-80. doi: 10.3892/or_00000338.
In experimental musculoskeletal oncology, there remains a need for animal models that can be used to assess the efficacy of new and innovative treatment methodologies for bone tumors. Rat plays a very important role in the bone field especially in the evaluation of metabolic bone diseases. The objective of this study was to develop a rat osteosarcoma model for evaluation of new surgical and molecular methods of treatment for extremity sarcoma. One hundred male SD rats weighing 125.45+/-8.19 g were divided into 5 groups and anesthetized intraperitoneally with 10% chloral hydrate. Orthotopic implantation models of rat osteosarcoma were performed by injecting directly into the SD rat femur with a needle for inoculation with SD tumor cells. In the first step of the experiment, 2x10(5) to 1x10(6) UMR106 cells in 50 microl were injected intraosseously into median or distal part of the femoral shaft and the tumor take rate was determined. The second stage consisted of determining tumor volume, correlating findings from ultrasound with findings from necropsia and determining time of survival. In the third stage, the orthotopically implanted tumors and lung nodules were resected entirely, sectioned, and then counter stained with hematoxylin and eosin for histopathologic evaluation. The tumor take rate was 100% for implants with 8x10(5) tumor cells or more, which was much less than the amount required for subcutaneous implantation, with a high lung metastasis rate of 93.0%. Ultrasound and necropsia findings matched closely (r=0.942; p<0.01), which demonstrated that Doppler ultrasonography is a convenient and reliable technique for measuring cancer at any stage. Tumor growth curve showed that orthotopically implanted tumors expanded vigorously with time-lapse, especially in the first 3 weeks. The median time of survival was 38 days and surgical mortality was 0%. The UMR106 cell line has strong carcinogenic capability and high lung metastasis frequency. The present rat osteosarcoma model was shown to be feasible: the take rate was high, surgical mortality was negligible and the procedure was simple to perform and easily reproduced. It may be a useful tool in the investigation of antiangiogenic and anticancer therapeutics. Ultrasound was found to be a highly accurate tool for tumor diagnosis, localization and measurement and may be recommended for monitoring tumor growth in this model.
在实验性肌肉骨骼肿瘤学领域,仍然需要能够用于评估骨肿瘤新型创新治疗方法疗效的动物模型。大鼠在骨研究领域发挥着非常重要的作用,尤其是在代谢性骨病的评估方面。本研究的目的是建立一种大鼠骨肉瘤模型,用于评估肢体肉瘤的新型手术和分子治疗方法。将100只体重为125.45±8.19 g的雄性SD大鼠分为5组,并用10%水合氯醛腹腔注射麻醉。通过用接种针直接将SD肿瘤细胞注射到SD大鼠股骨中,建立大鼠骨肉瘤原位植入模型。在实验的第一步,将50 μl含2×10⁵至1×10⁶个UMR106细胞的悬液骨内注射到股骨干的中部或远端,测定肿瘤接种成功率。第二阶段包括测定肿瘤体积,将超声检查结果与尸检结果进行关联,并确定存活时间。在第三阶段,将原位植入的肿瘤和肺结节完全切除、切片,然后用苏木精和伊红复染进行组织病理学评估。肿瘤细胞数为8×10⁵个或更多的植入物的肿瘤接种成功率为100%,这远低于皮下植入所需的细胞数量,肺转移率高达93.0%。超声检查结果与尸检结果密切匹配(r = 0.942;p < 0.01),这表明多普勒超声检查是在任何阶段测量肿瘤的一种方便可靠技术。肿瘤生长曲线显示,原位植入的肿瘤随时间推移生长旺盛,尤其是在最初3周。中位存活时间为38天,手术死亡率为0%。UMR106细胞系具有很强的致癌能力和高肺转移频率。目前的大鼠骨肉瘤模型被证明是可行的:接种成功率高,手术死亡率可忽略不计,操作简单且易于重复。它可能是研究抗血管生成和抗癌治疗药物的有用工具。超声被发现是用于肿瘤诊断、定位和测量的高度准确工具,可能推荐用于监测该模型中的肿瘤生长。